April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

Merck & Co says that it has won US Food and Drug Administration clearance for a new version of its osteoporosis treatment, Fosamax Plus D (alendronate sodium/cholecalciferol) – a once-weekly tablet ...

has won approval of a combined therapy for brittle bone disease. The Food and Drug Administration approved the once-weekly Fosamax Plus D, an osteoporosis treatment containing the drug Fosamax and ...

Merck & Company's Fosamax Plus D (alendronate sodium/cholecalciferol), a single once-weekly tablet containing 70 mg Fosamax (alendronate sodium) and 2800 IU vitamin D3, representing seven days worth ...

At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug's main patent today, bringing patients hefty savings. Two ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Is there any food or drink I need to avoid. Alendronate Osteoporosis Prevention Fosamax d 70mg Group. More than one-third of patients in this study reported Fosamax d 70mg however, other multivalent ...

Merck Sharp & Dohme New Zealand (MSDNZ) has gained registration for its osteoporosis medication FOSAMAX PLUS™ 5600 IU. MSDNZ Managing Director, Alister Brown, says "This will be welcome news for the ...